Business Daily from THE HINDU group of publications Wednesday, Dec 13, 2006 ePaper |
|
|
|
|
|
|
|
Corporate
-
Outlook Dr Lal PathLabs plans pan-India presence Our Bureau,
New Delhi , Dec. 12 Dr Lal PathLabs Pvt Ltd will be doubling its infrastructure and hopes to have 50 pathology laboratories across the country by March 2009. "Dr Lal PathLabs has set for itself the goal of leading the process of consolidation and garner a market share of 10 per cent in the next 2 to 3 years," said Dr O.P. Manchanda, COO, Dr Lal PathLabs. The company hopes to meet the expansion plans through acquisitions and new laboratories funded by internal accruals, venture fund Sequoia Capital and debt. With two new laboratories in Faridabad and Ghaziabad last month, and two scheduled for Mumbai and Kolkata this month, the company says its well on its way to strengthening its pan-Indian presence having started operations in Bangalore, Jaipur, Chandigarh and Guwahati recently. Dr Arvind Lal, Chairman and Managing Director, said, "Given our credentials of being the oldest and the most sophisticated lab in the country and having successfully operated 20 labs all over India, we sensed a great need of setting up quality testing labs across India, especially since 70 per cent of treatment decisions are based on laboratory tests." Dr Lal Pathlabs are accredited by the College of American Pathologists and the National Accreditation Board for Testing and Calibration Laboratories. According to Dr Lal, currently they treat 1.6 million patients a year through their 25 labs and 450 collection centres across 250 cities of India.
More Stories on : Outlook | Medical Institutions & Hospitals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|